TXNIP targeting has provided considerable and unique therapeutic opportunities concerning T1DM, T2DM, and the prevention of their long-term complications by improving insulin secretion and sensitivity along with β-cell function and integrity. Here, INS is linked to type 1 diabetes mellitus.